iCare ILLUME screening solution instantly detects early signs of DR, AMD, and Glaucoma
How does iCare ILLUME work?
The AI detects early signs of diabetic retinopathy, AMD and glaucoma instantly and classifies the results according to severity based on international classifications. This allows healthcare professionals to focus on patients who are most in need of specialized care.
With iCare ILLUME, you benefit from efficient processing for higher throughput and reliable results that match the level of a professional human grader.
Get a report with severity scoring
The iCare ILLUME solution uses partner’s AI deep learning technology to analyze the fundus images captured by iCare DRSplus and generates a patient report with severity scoring for AMD and DR based on international standards (ICDR, AREDS). For glaucoma (GLC), the AI will indicate whether there is a glaucoma suspicion.
The report contains
1. Scores for AMD and DR indicating the severity of the disease and for GLC the AI will indicate whether there is a glaucoma suspicion
2. In cases where needed, recommendations to refer patients for further testing
3. Heatmaps highlighting bright and red lesions
4. Quality assessment of the input images
Diabetic retinopathy
DR is the leading cause of vision loss in adults aged 20–74 years. Over one-third of an estimated 285 million people worldwide with diabetes show signs of DR. DR is on the rise due to the increasing prevalence of diabetes, the aging population, and the increasing life expectancy of those with diabetes.
Age-related macular degeneration
AMD is a progressive, incurable disease, leading to severe visual impairment. It affects an estimated 170 million individuals worldwide and is one of the leading causes of visual disability. High prevalence makes periodic screening crucial to prevent the growing healthcare burden.
Glaucoma
Glaucoma is a chronic, degenerative, and irreversible disorder of the optic nerve that causes visual field damage. It affects an estimated 80 million people worldwide, making it the second leading cause of blindness globally. Periodic testing enables early diagnosis and helps prevent visual disability.
-
Interested?
Local qualified iCare distributors are ready to help you with all matters related to iCare products and services.
Contact us -
Product materials
Get support materials for your iCare products by filling in the form.
Material request
Software Solutions
-
iCare ILLUME iCare ILLUME offers fast, fully automated imaging and processing with artificial intelligence, superior-quality images for higher throughput and a more focused and controlled referral flow.Read more › -
iCare CLINIC The iCare CLINIC cloud software stores long term IOP data from the iCare HOME2, iCare HOME and iCare IC200 tonometers provides tools for versatile analysis and reporting of the data.Read more ›
-
iCare OCULO iCare OCULO is a world-leading eye care platform that connects ophthalmology, optometry, primary care, emergency rooms, and patients to share clinical information and enhance referrals, triage, and collaborative care.Read more ›
